Results of ECP in patients with acute steroid-refractory GVHD
Pt. no. . | Acute GVHD . | Steroids before ECP . | Interval SCT-ECP (d) . | Response to ECP . | Time off ECP (mo) . | Outcome . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Grade . | Onset (d) . | Max dose (mg) . | Duration (d) . | Skin . | Liver . | Gut . | ||||
1 | III | 13 | 2 | 32 | 45 | CR | CR | NA | 16 | Alive, CR |
2 | III | 12 | 4 | 20 | 36 | CR | CR | NA | 19 | Alive, chron extens |
3 | IV | 13 | 10 | 15 | 34 | PR | NR | NR | NA | Death (sepsis) |
4 | II | 13 | 2 | 29 | 42 | CR | CR | NA | NA | Death (relapse) |
5 | IV | 13 | 10 | 29 | 42 | PR | NA | NR | NA | Death (sepsis) |
6 | IV | 27 | 2 | 17 | 44 | NC | CR | NA | NA | Death (sepsis) |
7 | IV | 15 | 10 | 22 | 37 | CR | CR | NA | NA | Death (relapse) |
8 | II | 21 | 2 | 49 | 70 | CR | NA | NA | 41 | Alive, CR |
9 | II | 14 | 4 | 23 | 37 | CR | NA | NA | 24 | Alive, CR |
10 | II | 30 | 2 | 26 | 57 | CR | NA | NA | NA | Death (relapse) |
11 | II | 26 | 2 | 9 | 44 | CR | NA | NA | 14 | Alive, chron lim |
12 | II | 13 | 2 | 23 | 36 | CR | NA | NA | 15 | Alive, CR |
13 | II | 18 | 3 | 21 | 48 | CR | NA | NA | 25 | Alive, CR |
14 | IV | 25 | 10 | 9 | 34 | PR | CR | NA | 9 | Alive, chron extens |
15 | III | 18 | 2 | 24 | 42 | CR | CR | NA | 16 | Alive, CR |
16 | IV | 14 | 5 | 23 | 38 | PR | NR | NR | NA | Death (sepsis) |
17 | II | 33 | 2 | 9 | 42 | CR | CR | NA | 5 | Alive, CR |
18 | II | 19 | 2 | 14 | 42 | CR | NA | NA | 1 | Alive, CR |
19 | IV | 17 | 2.5 | 20 | 37 | NC | NC | NA | NA | Death (H zost) |
20 | IV | 10 | 2 | 10 | 20 | NC | NR | NR | NA | Death (MOF) |
21 | II | 32 | 2 | 9 | 42 | NC | NA | NA | NA* | Alive, NC |
Pt. no. . | Acute GVHD . | Steroids before ECP . | Interval SCT-ECP (d) . | Response to ECP . | Time off ECP (mo) . | Outcome . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Grade . | Onset (d) . | Max dose (mg) . | Duration (d) . | Skin . | Liver . | Gut . | ||||
1 | III | 13 | 2 | 32 | 45 | CR | CR | NA | 16 | Alive, CR |
2 | III | 12 | 4 | 20 | 36 | CR | CR | NA | 19 | Alive, chron extens |
3 | IV | 13 | 10 | 15 | 34 | PR | NR | NR | NA | Death (sepsis) |
4 | II | 13 | 2 | 29 | 42 | CR | CR | NA | NA | Death (relapse) |
5 | IV | 13 | 10 | 29 | 42 | PR | NA | NR | NA | Death (sepsis) |
6 | IV | 27 | 2 | 17 | 44 | NC | CR | NA | NA | Death (sepsis) |
7 | IV | 15 | 10 | 22 | 37 | CR | CR | NA | NA | Death (relapse) |
8 | II | 21 | 2 | 49 | 70 | CR | NA | NA | 41 | Alive, CR |
9 | II | 14 | 4 | 23 | 37 | CR | NA | NA | 24 | Alive, CR |
10 | II | 30 | 2 | 26 | 57 | CR | NA | NA | NA | Death (relapse) |
11 | II | 26 | 2 | 9 | 44 | CR | NA | NA | 14 | Alive, chron lim |
12 | II | 13 | 2 | 23 | 36 | CR | NA | NA | 15 | Alive, CR |
13 | II | 18 | 3 | 21 | 48 | CR | NA | NA | 25 | Alive, CR |
14 | IV | 25 | 10 | 9 | 34 | PR | CR | NA | 9 | Alive, chron extens |
15 | III | 18 | 2 | 24 | 42 | CR | CR | NA | 16 | Alive, CR |
16 | IV | 14 | 5 | 23 | 38 | PR | NR | NR | NA | Death (sepsis) |
17 | II | 33 | 2 | 9 | 42 | CR | CR | NA | 5 | Alive, CR |
18 | II | 19 | 2 | 14 | 42 | CR | NA | NA | 1 | Alive, CR |
19 | IV | 17 | 2.5 | 20 | 37 | NC | NC | NA | NA | Death (H zost) |
20 | IV | 10 | 2 | 10 | 20 | NC | NR | NR | NA | Death (MOF) |
21 | II | 32 | 2 | 9 | 42 | NC | NA | NA | NA* | Alive, NC |
Max indicates maximal; chron, chronic; lim, limited; extens, extensive; CR, complete response; PR, partial response; NC, no change; NR, no response; MOF, multiorgan failure; H zost, herpes zoster infection; NA, not applicable.
Patient is currently under therapy.